SCHEMBL6667428

SCHEMBL6667428

O=C(c1c[nH]c2ccc(CN3CCOCC3)cc2c1=O)N(Cc1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
HPGD P15428 4/20 0.51
KDM4E B2RXH2 3/20 0.51
GAA P10253 2/20 0.51
GLA P06280 1/20 0.51
HSD17B10 Q99714 3/20 0.45
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HRH3 Q9Y5N1 2/20 0.45
PDK1 Q15118 1/20 0.43
MAPT P10636 3/20 0.42
KMT2A Q03164 1/20 0.42
ALOX15 P16050 1/20 0.42
CFTR P13569 1/20 0.42
JAK2 O60674 1/20 0.42
TSHR P16473 1/20 0.41
BACE1 P56817 1/20 0.40
RGS12 O14924 1/20 0.40
HTT P42858 1/20 0.40
MAPK14 Q16539 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6959107 0.96 ALDH1A1 (0.47) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL6957798 0.92 ALDH1A1 (0.45) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL6959053 0.92 ALDH1A1 (0.45) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL6958938 0.91 ALDH1A1 (0.45) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL6958785 0.91 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL7199782 0.90 ALDH1A1 (0.45) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL6964935 0.90 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL6959857 0.90 ALDH1A1 (0.45) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL6961431 0.88 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EGAAGLA
SCHEMBL6955928 0.88 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004019932-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO claimed
EP-1292575-A2 1-ARYL-4-OXO-1,4-DIHYDRO-3-QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2003-03-19 EP claimed
WO-2001098275-A2 1-ARYL-4-OXO-1,4-DIHYDRO-3-QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2001-12-27 WO claimed